BCA
STIM icon

Bay Colony Advisors’s Neuronetics STIM Stock Holding History

Bay Colony Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-86,919
Closed -$303K – 546
2025
Q2 		$303K Buy
86,919
+70,709
+436% +$279K 0.04% 342
2025
Q1 		$61.1K Buy
+16,210
New +$59.2K 0.01% 436

Other funds holding STIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bay Colony Advisors's STIM Position: Q3 2025 in Review

Bay Colony Advisors sold out of Neuronetics (STIM) in Q3 2025, closing a stake of 86,919 shares — an estimated $303K sold.

Bay Colony Advisors first reported a position in STIM in Q1 2025 and held it in 2 quarters. The position peaked at $303K in Q2 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q3 2025.

  • Bay Colony Advisors reported no remaining Neuronetics position as of Q3 2025 after selling out during the quarter.
  • Bay Colony Advisors sold 86,919 Neuronetics shares in Q3 2025, an estimated $303K.
  • Bay Colony Advisors first reported a position in Neuronetics in Q1 2025 and held it in 2 quarters.
  • Bay Colony Advisors's Neuronetics position peaked at $303K in Q2 2025.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q3 2025.

Based on Bay Colony Advisors's 13F filing for Q3 2025, filed 24 Oct 2025.